Harvard Business Review

NOVEMBER 9, 2011

That's what we found when we studied the top management teams of companies in Europe over the past three years. Part of the problem may be in the backgrounds that companies desired: 85% of COOs had experience in operations, strategy, or finance. Does your COO have the best shot at becoming the next CEO?

COO 13

COO Sample Telecommunications Automotive 13

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Resistant forms continue to thrive, and increased travel makes the global threat very real.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. The failure stemmed from resistance in the U.S. What builds management perspectives?

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

FEBRUARY 24, 2015

Does the business have a complete, balanced, and cohesive management team? Successful spin-offs tend to have a management team that comprises both insiders and outsiders. The outsiders provide new blood in support functions such as finance, legal, or administration. and the competitive intensity of its industry.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

FEBRUARY 4, 2013

Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. The future, he argued, lies with institutional forms based on networks, "an open, fluid team of teams". Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. HR has the job of developing the human capabilities needed to capture the IoT opportunity.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

JUNE 20, 2017

While consumer spending has proven resilient, with same-store retail sales rising 6% YOY in April , most multinational corporations are developing contingency plans to mitigate risks to their businesses and reassessing the country’s role in their global market portfolio and supply chains. Renegotiating NAFTA.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8

Harvard Business Review

AUGUST 23, 2016

Republicans generally favor developing a pipeline of diverse candidates through director advocacy and mentorship, while Democrats are more likely to favor requiring that every director slate include diverse candidates, or that boards implement targets for diverse membership. Why does all this matter?

Politics 8

Politics Committee Telecommunications Diversity 8